JJ, M., PD, S., PJ, v. L., R, T., B, H., Q, N., . . . L, E. (2015). Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(8), 1185. https://doi.org/10.2967/jnumed.115.160382
Chicago Style (17th ed.) CitationJJ, Morigi, et al. "Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 56, no. 8 (2015): 1185. https://doi.org/10.2967/jnumed.115.160382.
MLA (9th ed.) CitationJJ, Morigi, et al. "Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 56, no. 8, 2015, p. 1185, https://doi.org/10.2967/jnumed.115.160382.
